{"parse":{"title":"Rho(D) immune globulin","pageid":3365974,"revid":850581461,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">\"Anti-D\" redirects here. For the song, see <a href=\"/wiki/Anti-D_(song)\" title=\"Anti-D (song)\">Anti-D (song)</a>.</div>\n<table class=\"infobox\" style=\"width:22em;border-spacing:2px;\"><caption><span title=\"International nonproprietary name (INN): Rho(D) immune globulin\">Rho(D) immune globulin</span></caption><tbody><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Clinical data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Drug_nomenclature#Trade_names\" title=\"Drug nomenclature\">Trade names</a></th><td>\nWinRho, RhoGAM, <a href=\"#Brand_names\">others</a></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\">Synonyms</th><td>\nRh<sub>0</sub>(D) immune globulin, anti-D (Rh<sub>0</sub>) immunoglobulin</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/American_Society_of_Health-System_Pharmacists\" title=\"American Society of Health-System Pharmacists\">AHFS</a>/<a href=\"/wiki/Drugs.com\" title=\"Drugs.com\">Drugs.com</a></th><td>\n<span title=\"www.drugs.com\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/monograph/rho-d-immune-globulin.html\">Monograph</a></span></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Pregnancy_category\" title=\"Pregnancy category\">Pregnancy<br />category</a></th><td>\n<div class=\"plainlist\">\n<ul><li>C</li></ul>\n</div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Route_of_administration\" title=\"Route of administration\">Routes of<br />administration</a></th><td>\nintramuscular injection</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Anatomical_Therapeutic_Chemical_Classification_System\" title=\"Anatomical Therapeutic Chemical Classification System\">ATC code</a></th><td>\n<div class=\"plainlist\"><ul><li><a href=\"/wiki/ATC_code_J06\" title=\"ATC code J06\">J06BB01</a>&#x20;(<span title=\"www.whocc.no\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.whocc.no/atc_ddd_index/?code=J06BB01\">WHO</a></span>)&#x20;</li></ul></div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Identifiers</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChemSpider\" title=\"ChemSpider\">ChemSpider</a></th><td>\n<div class=\"plainlist\"><ul><li>none</li></ul></div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\"><span style=\"font-weight:normal;\">&#160;<sup><img alt=\"\u2612\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png\" width=\"7\" height=\"8\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x\" data-file-width=\"525\" data-file-height=\"600\" /><span style=\"display:none\">N</span><img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup>&#160;<a href=\"/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation\" title=\"Wikipedia:WikiProject Chemicals/Chembox validation\">(what is this?)</a></span><span style=\"font-weight:normal;\">&#160;&#160;<span class=\"reflink plainlinks nourlexpansion\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=477162599&amp;page2=Rho%28D%29+immune+globulin\">(verify)</a></span></span></th></tr></tbody></table>\n<p><b>Rh<sub>o</sub>(D) immune globulin</b> (<b>RhIG</b>) is a medication used to prevent <a href=\"/wiki/Rh_isoimmunization\" class=\"mw-redirect\" title=\"Rh isoimmunization\">Rh isoimmunization</a> in mothers who are <a href=\"/wiki/Rh_negative\" class=\"mw-redirect\" title=\"Rh negative\">Rh negative</a> and to treat <a href=\"/wiki/Idiopathic_thrombocytopenic_purpura\" class=\"mw-redirect\" title=\"Idiopathic thrombocytopenic purpura\">idiopathic thrombocytopenic purpura</a> (ITP) in people who are <a href=\"/wiki/Rh_positive\" class=\"mw-redirect\" title=\"Rh positive\">Rh positive</a>.<sup id=\"cite_ref-AHFS2017_1-0\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> It is often given both during and following <a href=\"/wiki/Pregnancy\" title=\"Pregnancy\">pregnancy</a>.<sup id=\"cite_ref-AHFS2017_1-1\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> It may also be used when Rh negative people are given Rh positive blood.<sup id=\"cite_ref-AHFS2017_1-2\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> It is given by <a href=\"/wiki/Intramuscular_injection\" title=\"Intramuscular injection\">injection into muscle</a> or a <a href=\"/wiki/Intravenous\" class=\"mw-redirect\" title=\"Intravenous\">vein</a>.<sup id=\"cite_ref-AHFS2017_1-3\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> A single dose lasts 2 to 4 weeks.<sup id=\"cite_ref-AHFS2017_1-4\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup>\n</p><p>Common side effects include <a href=\"/wiki/Fever\" title=\"Fever\">fever</a>, headache, pain at the site of injection, and <a href=\"/wiki/Hemolysis\" title=\"Hemolysis\">red blood cell breakdown</a>.<sup id=\"cite_ref-AHFS2017_1-5\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> Other side effects include <a href=\"/wiki/Allergic_reactions\" class=\"mw-redirect\" title=\"Allergic reactions\">allergic reactions</a>, <a href=\"/wiki/Kidney_problems\" class=\"mw-redirect\" title=\"Kidney problems\">kidney problems</a>, and a very small risk of viral infections.<sup id=\"cite_ref-AHFS2017_1-6\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> In those with ITP, the amount of red blood cell breakdown may be significant.<sup id=\"cite_ref-AHFS2017_1-7\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> Use is safe with <a href=\"/wiki/Breastfeeding\" title=\"Breastfeeding\">breastfeeding</a>.<sup id=\"cite_ref-AHFS2017_1-8\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> Rho(D) immune globulin is made up of <a href=\"/wiki/Antibodies\" class=\"mw-redirect\" title=\"Antibodies\">antibodies</a> to the <a href=\"/wiki/Antigen\" title=\"Antigen\">antigen</a> Rh<sub>o</sub>(D) present on some <a href=\"/wiki/Red_blood_cells\" class=\"mw-redirect\" title=\"Red blood cells\">red blood cells</a>.<sup id=\"cite_ref-AHFS2017_1-9\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup> It is believed to work by blocking a person's immune system from recognizing this antigen.<sup id=\"cite_ref-AHFS2017_1-10\" class=\"reference\"><a href=\"#cite_note-AHFS2017-1\">&#91;1&#93;</a></sup>\n</p><p>Rh<sub>o</sub>(D) immune globulin came into medical use in the 1960s.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> It is on the <a href=\"/wiki/World_Health_Organization%27s_List_of_Essential_Medicines\" class=\"mw-redirect\" title=\"World Health Organization&#39;s List of Essential Medicines\">World Health Organization's List of Essential Medicines</a>, the most effective and safe medicines needed in a <a href=\"/wiki/Health_system\" title=\"Health system\">health system</a>.<sup id=\"cite_ref-WHO19th_3-0\" class=\"reference\"><a href=\"#cite_note-WHO19th-3\">&#91;3&#93;</a></sup> In the United Kingdom, a 1,500-unit (300-mcg) vial costs the <a href=\"/wiki/NHS\" class=\"mw-redirect\" title=\"NHS\">NHS</a> about 58 pounds.<sup id=\"cite_ref-BNF69_4-0\" class=\"reference\"><a href=\"#cite_note-BNF69-4\">&#91;4&#93;</a></sup> In the United States, a course of treatment costs more than 200 USD.<sup id=\"cite_ref-Ric2015_5-0\" class=\"reference\"><a href=\"#cite_note-Ric2015-5\">&#91;5&#93;</a></sup> It is made from <a href=\"/wiki/Human_blood_plasma\" class=\"mw-redirect\" title=\"Human blood plasma\">human blood plasma</a>.<sup id=\"cite_ref-BNF69_4-1\" class=\"reference\"><a href=\"#cite_note-BNF69-4\">&#91;4&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Medical_uses\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Medical uses</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Following_delivery\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Following delivery</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Immune_thrombocytopenia\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Immune thrombocytopenia</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Contraindications\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Contraindications</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#History\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Society_and_culture\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Society and culture</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Manufacturing_and_safety\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Manufacturing and safety</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Routes_of_administration\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Routes of administration</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Names\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">Names</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#See_also\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#External_links\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Medical_uses\">Medical uses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=1\" title=\"Edit section: Medical uses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In a pregnancy where the mother is Rho(D)-negative and the father is Rho(D)-positive, the probability of the fetus having Rho(D)-positive blood is dependent on whether the father is <a href=\"/wiki/Homozygous\" class=\"mw-redirect\" title=\"Homozygous\">homozygous</a> for Rho(D)-positive (i.e., both Rho(D) alleles are positive) or <a href=\"/wiki/Heterozygous\" class=\"mw-redirect\" title=\"Heterozygous\">heterozygous</a> (i.e., one Rho(D) allele is positive and the other negative). If the father is homozygous, the fetus will necessarily be Rho(D)-positive, as the father will necessarily pass on a Rho(D)-positive allele. If the father is heterozygous, there is a 50% chance that the fetus will be Rho(D)-positive, as he will randomly pass on either the Rho(D)-positive allele or the Rho(D)-negative allele.\n</p><p>If a fetus is Rho(D)-positive and the mother is Rho(D)-negative, the mother is at risk of Rho(D) alloimmunization, where the mother mounts an immune response (develops <a href=\"/wiki/Antibodies\" class=\"mw-redirect\" title=\"Antibodies\">antibodies</a>) to fetal red blood cells. This usually has minimal effect on the first such pregnancy; but, in a second such pregnancy, pre-existing maternal antibodies to Rho(D) antigens on fetal red blood cells often leads to <a href=\"/wiki/Erythroblastosis_fetalis\" class=\"mw-redirect\" title=\"Erythroblastosis fetalis\">erythroblastosis fetalis</a>, a condition which can be fatal to the fetus. In countries without RhIG protocols, as many as 14% of affected fetuses are stillborn and 50% of live births result in neonatal death or brain injury.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p><p>Because of this severe complication, the <a href=\"/wiki/American_College_of_Obstetricians_and_Gynecologists\" class=\"mw-redirect\" title=\"American College of Obstetricians and Gynecologists\">American College of Obstetricians and Gynecologists</a> (ACOG) recommends that all Rho(D)-negative mothers, regardless of fetal blood type, receive RhIG at about 28 weeks gestation, and again shortly after delivery.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> It should be given within 3 days of a potential exposure to Rh positive blood from the baby such as may occur during miscarriage, trauma, or delivery.<sup id=\"cite_ref-BNF69_4-2\" class=\"reference\"><a href=\"#cite_note-BNF69-4\">&#91;4&#93;</a></sup> The '28 weeks' recommendation comes from the fact that 92% of women who develop an anti-D during pregnancy do so at or after 28 weeks gestation.<sup id=\"cite_ref-Roback_2008_8-0\" class=\"reference\"><a href=\"#cite_note-Roback_2008-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-Bowman_JM_1988_129\u201350_9-0\" class=\"reference\"><a href=\"#cite_note-Bowman_JM_1988_129\u201350-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-D_Alloimmunization._ACOG_Practice_Bulletin_Number_4_1999_10-0\" class=\"reference\"><a href=\"#cite_note-D_Alloimmunization._ACOG_Practice_Bulletin_Number_4_1999-10\">&#91;10&#93;</a></sup> It is given by intramuscular injection as part of modern routine <a href=\"/wiki/Antenatal\" class=\"mw-redirect\" title=\"Antenatal\">antenatal</a> care. Despite excellent results, the medication retains an FDA <a href=\"/wiki/Pregnancy_category\" title=\"Pregnancy category\">Pregnancy Category</a> C.\n</p><p>RhIG is recommended in the UK after antenatal pathological events that are likely to cause a feto\u2013maternal hemorrhage.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> Applicable 'pathologic events' include accidents which may induce fetomaternal hemorrhage (motor vehicle accidents, falls, abdominal trauma), following obstetric/gynecologic procedures during pregnancy, and at the time of threatened- or spontaneous-/elective <a href=\"/wiki/Abortion\" title=\"Abortion\">abortions</a>, regardless of gestational age.\n</p><p>There is insufficient evidence that the use of Rho(D) immune globulin after a spontaneous miscarriage is needed and a <a href=\"/wiki/Cochrane_review\" class=\"mw-redirect\" title=\"Cochrane review\">Cochrane review</a> recommends that local practices be followed.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>\n</p><p>In a Rhesus-negative mother, Rh<sub>o</sub>(D) immune globulin can prevent temporary sensitization of the maternal immune system to Rh D <a href=\"/wiki/Antigen\" title=\"Antigen\">antigens</a>, which can cause rhesus disease in the current or in subsequent pregnancies. With the widespread use of Rho(D) immune globulin, <a href=\"/wiki/Rh_disease\" title=\"Rh disease\">Rh disease</a> of the <a href=\"/wiki/Fetus\" title=\"Fetus\">fetus</a> and <a href=\"/wiki/Newborn\" class=\"mw-redirect\" title=\"Newborn\">newborn</a> has almost disappeared in the developed world. The risk that a D-negative mother can be <a href=\"/wiki/Alloimmunity\" title=\"Alloimmunity\">alloimmunized</a> by a D-positive fetus can be reduced from approximately 16% to less than 0.1% by the appropriate administration of RhIG.<sup id=\"cite_ref-Roback_2008_8-1\" class=\"reference\"><a href=\"#cite_note-Roback_2008-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-Bowman_JM_1988_129\u201350_9-1\" class=\"reference\"><a href=\"#cite_note-Bowman_JM_1988_129\u201350-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>\n</p><p>Rho(D) immune globulin is composed of IgG antibodies and therefore is able to cross the placenta. In rare cases this can cause a baby to have a weakly positive <a href=\"/wiki/Direct_antiglobulin_test\" class=\"mw-redirect\" title=\"Direct antiglobulin test\">DAT</a> (<a href=\"/wiki/Direct_antiglobulin_test\" class=\"mw-redirect\" title=\"Direct antiglobulin test\">direct antiglobulin test</a>) due to sensitization of fetal cells from mothers who have received multiple doses of Rho(D) immune globulin. However, no treatment is necessary as the clinical course is benign.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Following_delivery\">Following delivery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=2\" title=\"Edit section: Following delivery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A D-negative mother who is not alloimmunized to D should also receive an appropriate dose of RhIG after delivery of a D-positive infant. After delivery, a cord blood sample from infants born to D-negative mothers should be tested for the D antigen.  If the neonate is D-negative, no further RhIG is needed.  However, if the infant is D-positive, the mother should have a postpartum blood sample screened for fetomaternal hemorrhage in order to determine the appropriate dosage of RhIG to be administered.  (the presence of residual anti-D from antepartum RhIG administration does NOT indicate ongoing protection from alloimmunization- repeat administration of RhIG is necessary).\n</p><p>The <a href=\"/wiki/Rosette_test\" class=\"mw-redirect\" title=\"Rosette test\">rosette test</a> is a sensitive method to detect fetomaternal hemorrhage of 10 cc or more.  A rosette test will be positive if fetal D-positive cells are present in the maternal sample, indicating a significantly large fetomaternal hemorrhage has occurred.  A rosette test may be falsely positive if the mother is positive for the <a href=\"/wiki/Weak_D\" class=\"mw-redirect\" title=\"Weak D\">weak D</a> phenotype and falsely negative if the neonate is weak D.  If the rosette test is negative, then a dose of 300 micrograms of RhIG is given (sufficient to prevent alloimmunization after delivery in 99% of cases).<sup id=\"cite_ref-Roback_2008_8-2\" class=\"reference\"><a href=\"#cite_note-Roback_2008-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>  The RhIG dose suppresses the immune response to up to 30 cc of whole fetal blood.\n</p><p>If a fetomaternal hemorrhage in excess of 30 cc has occurred, additional testing is mandatory in order to determine the appropriate dosage of RhIG to prevent alloimmunization.  A positive rosette test should be followed by a quantitative test such as the <a href=\"/wiki/Kleihauer-Betke_test\" class=\"mw-redirect\" title=\"Kleihauer-Betke test\">Kleihauer-Betke test</a> (acid/elution) or an alternative approach such as <a href=\"/wiki/Flow_cytometry\" title=\"Flow cytometry\">flow cytometry</a>.  See article on <a href=\"/wiki/Kleihauer-Betke_test\" class=\"mw-redirect\" title=\"Kleihauer-Betke test\">Kleihauer-Betke test</a> for details on how the volume of fetomaternal hemorrhage is calculated.\n</p><p>The dosage of RhIG is calculated from the volume of fetal hemorrhage (in mL).  Ex: 50 mL fetal hemorrhage / 30 ml = 1.667 (round up to 2) then add 1 = 3 vials of RhIG.\n</p><p>Postpartum RhIG should be administered within 72 hours of delivery.  If prophylaxis is delayed, the likelihood that alloimmunization will be prevented is decreased.  However, ACOG still recommends that RhIG be administered because partial protection still occurs.<sup id=\"cite_ref-Roback_2008_8-3\" class=\"reference\"><a href=\"#cite_note-Roback_2008-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-D_Alloimmunization._ACOG_Practice_Bulletin_Number_4_1999_10-1\" class=\"reference\"><a href=\"#cite_note-D_Alloimmunization._ACOG_Practice_Bulletin_Number_4_1999-10\">&#91;10&#93;</a></sup>  If the D-type of a newborn or stillborn is unknown or cannot be determined, RhIG should be administered.\n</p>\n<h3><span class=\"mw-headline\" id=\"Immune_thrombocytopenia\">Immune thrombocytopenia</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=3\" title=\"Edit section: Immune thrombocytopenia\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Primary <a href=\"/wiki/Immune_thrombocytopenia\" class=\"mw-redirect\" title=\"Immune thrombocytopenia\">immune thrombocytopenia</a> (ITP) is an acquired immune-mediated disorder characterized by isolated <a href=\"/wiki/Thrombocytopenia\" title=\"Thrombocytopenia\">thrombocytopenia</a>, defined as a peripheral blood platelet count less than 100 x 10<sup>9</sup>/L, and the absence of any obvious initiating and/or underlying cause of the thrombocytopenia.  Symptoms of ITP include abnormal bleeding and bruising due to the reduction in <a href=\"/wiki/Platelet_count\" class=\"mw-redirect\" title=\"Platelet count\">platelet count</a>.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup>  Rh<sub>o</sub>(D) Immune Globulin Intravenous [Human; Anti-D] is indicated for use in non-splenectomized, Rh<sub>o</sub>(D)-positive children with chronic or acute ITP, adults with chronic ITP, and children and adults with ITP secondary to HIV infection. Anti-D must be administered via the intravenous route when used in clinical situations requiring an increase in platelet count. The mechanism of action of anti-D is not fully understood; however, after administration the anti-D coated red blood cell complexes saturate <a href=\"/wiki/Fc_receptor\" title=\"Fc receptor\">Fc\u03b3 receptors</a> sites on <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a>, resulting in preferential destruction of <a href=\"/wiki/Red_blood_cells\" class=\"mw-redirect\" title=\"Red blood cells\">red blood cells</a> (RBCs), therefore sparing antibody-coated <a href=\"/wiki/Platelets\" class=\"mw-redirect\" title=\"Platelets\">platelets</a>.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> Anti-D is recommended as a first-line therapy for ITP, along with corticosteroids and intravenous immune globulin (IVIG).<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>  <a rel=\"nofollow\" class=\"external text\" href=\"http://www.winrho.com\">WinRho SDF</a> is an anti-D manufactured, distributed and marketed by <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cangene.com\">Cangene Corporation</a> in the US.\n</p>\n<h2><span class=\"mw-headline\" id=\"Contraindications\">Contraindications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=4\" title=\"Edit section: Contraindications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The following females are not candidates for RhIG:\n</p>\n<ul><li>D-negative females whose fetus is known to be D-negative</li>\n<li>D-negative females who have been previously alloimmunized to D (they have an anti-D antibody)</li>\n<li>Any D-positive females (women who test positive for the <a href=\"/wiki/Weak_D\" class=\"mw-redirect\" title=\"Weak D\">weak D</a> phenotype should be considered D-positive and not receive RhIG).</li></ul>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=5\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The first Rho(D) immune globulin treatment \"skymed\" was introduced by Ortho-Clinical Diagnostics, a subsidiary holding of <a href=\"/w/index.php?title=Jskymed&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Jskymed (page does not exist)\">Jskymed</a>, and was first administered on May 29, 1968 to Marianne Cummins in Teaneck, NJ.<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>\n</p><p>In 1996 ZLB Bioplasma (part of <a href=\"/wiki/CSL_Behring\" title=\"CSL Behring\">CSL Behring</a>) was given approval to sell Rhophylac in Europe. Effectiveness was demonstrated in a clinical trial in 2003 and in 2004 Rhophylac was approved in the United States.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Society_and_culture\">Society and culture</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=6\" title=\"Edit section: Society and culture\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Manufacturing_and_safety\">Manufacturing and safety</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=7\" title=\"Edit section: Manufacturing and safety\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Rho(D) immune globulin is a derivative of human <a href=\"/wiki/Blood_plasma\" title=\"Blood plasma\">plasma</a>. The most common way anti-D products are manufactured is by a form of the <a href=\"/wiki/Cohn_process\" title=\"Cohn process\">Cohn cold ethanol fractionation method</a> developed in the 1950s.  Variations of the Cohn method developed in the 1950s may not completely clear aggregates of immunoglobulins, which can cause problems for patients if administered intravenously, and is a primary reason why most anti-Ds are for intramuscular use only.  A non-Cohn manufacturing variation is ChromaPlus process approved by the <a href=\"/wiki/Food_and_Drug_Administration_(United_States)\" class=\"mw-redirect\" title=\"Food and Drug Administration (United States)\">U.S. Food and Drug Administration</a> (FDA) that is used to make Rhophylac.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup>  Rho(D) immune globulin may trigger an allergic reaction. Steps are taken in the plasma-donor screening process and the manufacturing process to eliminate bacterial and viral contamination, although a small, residual risk may remain for contamination with small viruses. There is also a theoretical possibility of transmission of the <a href=\"/wiki/Prion\" title=\"Prion\">prion</a> responsible for <a href=\"/wiki/Creutzfeldt%E2%80%93Jakob_disease\" title=\"Creutzfeldt\u2013Jakob disease\">Creutzfeldt\u2013Jakob disease</a>, or of other, unknown infectious agents.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Routes_of_administration\">Routes of administration</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=8\" title=\"Edit section: Routes of administration\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>RhIG can be administered either by either intramuscular (IM) or intravenous (IV) injection, depending on the preparation.  The IM-only preparation should never be administered IV due to the risk of complement system activation.  Multiple IM doses should be given at different sites or at different times within the 72-hour window.  Or, multiple IV doses can be administered according to the instructions in the package insert.\n</p>\n<h3><span class=\"mw-headline\" id=\"Names\">Names</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=9\" title=\"Edit section: Names\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Rh<sub>o</sub>(D) immune globulin is also spelled Rh<sub>0</sub>(D) immune globulin (letter <a href=\"/wiki/O\" title=\"O\">o</a> and digit <a href=\"/wiki/Zero\" class=\"mw-redirect\" title=\"Zero\">zero</a> are both widely attested; more at <a href=\"/wiki/Rh_blood_group_system#Rh_nomenclature\" title=\"Rh blood group system\">Rh blood group system - Rh nomenclature</a>).\n</p><p>Rhophylac is manufactured by CSL Limited. RhoGAM and MICRhoGam are brand names of Kedrion Biopharma. Other brand names are BayRHo-D, Gamulin Rh, HypRho-D Mini-Dose, Mini-Gamulin Rh, Partobulin SDF (<a href=\"/wiki/Baxter_International\" title=\"Baxter International\">Baxter</a>), Rhesonativ (Octapharma), and RhesuGam (NBI).  KamRho-D I.M. is a brand name of Kamada Ltd.\n</p><p>The United States <a href=\"/wiki/Distribution_(business)\" class=\"mw-redirect\" title=\"Distribution (business)\">distribution</a> rights for WinRho SDF (another brand name) were transferred from Baxter to the manufacturer, <a href=\"/wiki/Cangene\" title=\"Cangene\">Cangene</a>, in 2010; they had been held by Baxter since 2005.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup>  Sales of WinRho fell every year under the agreement with Baxter, the supposition being that Baxter was favoring the sale of its own product over WinRho; according to one analyst, \"WinRho was always an afterthought for a big company like Baxter.\"<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=10\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Rhesus_blood_group_system\" class=\"mw-redirect\" title=\"Rhesus blood group system\">Rhesus blood group system</a></li>\n<li><a href=\"/wiki/Blood_types\" class=\"mw-redirect\" title=\"Blood types\">Blood types</a></li>\n<li><a href=\"/wiki/Immunology\" title=\"Immunology\">Immunology</a></li>\n<li><a href=\"/wiki/Rh_disease\" title=\"Rh disease\">Rh disease</a></li>\n<li><a href=\"/wiki/James_Harrison_(blood_donor)\" title=\"James Harrison (blood donor)\">James Harrison (blood donor)</a> (Mr. Harrison's blood was used in the research process as this medicine was being created.)</li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=11\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 32em; -webkit-column-width: 32em; column-width: 32em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-AHFS2017-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-AHFS2017_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-AHFS2017_1-10\"><sup><i><b>k</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/monograph/rho-d-immune-globulin.html\">\"Rho(D) Immune Globulin\"</a>. <i>Drugs.com</i>. The American Society of Health-System Pharmacists. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170109021739/https://www.drugs.com/monograph/rho-d-immune-globulin.html\">Archived</a> from the original on 9 January 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 January</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Drugs.com&amp;rft.atitle=Rho%28D%29+Immune+Globulin&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Frho-d-immune-globulin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Hatfield, Nancy T. (2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.ca/books?id=WMsWpXjnWWYC&amp;pg=PA251\"><i>Broadribb's Introductory Pediatric Nursing</i></a>. Lippincott Williams &amp; Wilkins. p.&#160;251. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780781777063\" title=\"Special:BookSources/9780781777063\">9780781777063</a>. <a href=\"/wiki/OCLC\" title=\"OCLC\">OCLC</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/oclc/968617246\">968617246</a>  &#8211; via Google Books.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Broadribb%27s+Introductory+Pediatric+Nursing&amp;rft.pages=251&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft.date=2007&amp;rft_id=info%3Aoclcnum%2F968617246&amp;rft.isbn=9780781777063&amp;rft.aulast=Hatfield&amp;rft.aufirst=Nancy+T.&amp;rft_id=https%3A%2F%2Fbooks.google.ca%2Fbooks%3Fid%3DWMsWpXjnWWYC%26pg%3DPA251&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-WHO19th-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-WHO19th_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1\">\"WHO Model List of Essential Medicines (19th List)\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>World Health Organization</i>. April 2015. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1\">Archived</a> <span style=\"font-size:85%;\">(PDF)</span> from the original on 13 December 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 December</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization&amp;rft.atitle=WHO+Model+List+of+Essential+Medicines+%2819th+List%29&amp;rft.date=2015-04&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fmedicines%2Fpublications%2Fessentialmedicines%2FEML_2015_FINAL_amended_NOV2015.pdf%3Fua%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-BNF69-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-BNF69_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-BNF69_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-BNF69_4-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\"><i>British national formulary&#160;: BNF 69</i> (69 ed.). British Medical Association. 2015. p.&#160;871. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780857111562\" title=\"Special:BookSources/9780857111562\">9780857111562</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=British+national+formulary+%3A+BNF+69&amp;rft.pages=871&amp;rft.edition=69&amp;rft.pub=British+Medical+Association&amp;rft.date=2015&amp;rft.isbn=9780857111562&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ric2015-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ric2015_5-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Hamilton, Richart (2015). <i>Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition</i>. Jones &amp; Bartlett Learning. p.&#160;368. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9781284057560\" title=\"Special:BookSources/9781284057560\">9781284057560</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Tarascon+Pocket+Pharmacopoeia+2015+Deluxe+Lab-Coat+Edition&amp;rft.pages=368&amp;rft.pub=Jones+%26+Bartlett+Learning&amp;rft.date=2015&amp;rft.isbn=9781284057560&amp;rft.aulast=Hamilton&amp;rft.aufirst=Richart&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">\"Practice Bulletin No. 181: Prevention of Rh D Alloimmunization\". <i><a href=\"/wiki/American_Journal_of_Obstetrics_and_Gynecology\" title=\"American Journal of Obstetrics and Gynecology\">American Journal of Obstetrics and Gynecology</a></i>. <b>130</b>: e57\u2013e70. August 2017. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/AOG.0000000000002232\">10.1097/AOG.0000000000002232</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28742673\">28742673</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Obstetrics+and+Gynecology&amp;rft.atitle=Practice+Bulletin+No.+181%3A+Prevention+of+Rh+D+Alloimmunization.&amp;rft.volume=130&amp;rft.pages=e57-e70&amp;rft.date=2017-08&amp;rft_id=info%3Adoi%2F10.1097%2FAOG.0000000000002232&amp;rft_id=info%3Apmid%2F28742673&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nice.org.uk/guidance/TA41/?c=91520\">\"Pregnancy - routine anti-D prophylaxis for RhD-negative women\"</a>. <a href=\"/wiki/National_Institute_for_Health_and_Clinical_Excellence\" class=\"mw-redirect\" title=\"National Institute for Health and Clinical Excellence\">National Institute for Health and Clinical Excellence</a>. May 2002. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20080828175059/http://www.nice.org.uk/guidance/TA41/?c=91520\">Archived</a> from the original on 2008-08-28.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pregnancy+-+routine+anti-D+prophylaxis+for+RhD-negative+women&amp;rft.pub=National+Institute+for+Health+and+Clinical+Excellence&amp;rft.date=2002-05&amp;rft_id=http%3A%2F%2Fwww.nice.org.uk%2Fguidance%2FTA41%2F%3Fc%3D91520&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Roback_2008-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Roback_2008_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Roback_2008_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Roback_2008_8-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Roback_2008_8-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\">Roback et al. AABB Technical Manual, 16th Ed. Bethesda, AABB Press, 2008.</span>\n</li>\n<li id=\"cite_note-Bowman_JM_1988_129\u201350-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Bowman_JM_1988_129\u201350_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Bowman_JM_1988_129\u201350_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bowman JM (1988). \"The Prevention of Rh Immunization\". <i>Transfus Med Rev</i>. <b>2</b>: 129\u201350.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transfus+Med+Rev&amp;rft.atitle=The+Prevention+of+Rh+Immunization&amp;rft.volume=2&amp;rft.pages=129-50&amp;rft.date=1988&amp;rft.au=Bowman+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-D_Alloimmunization._ACOG_Practice_Bulletin_Number_4_1999-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-D_Alloimmunization._ACOG_Practice_Bulletin_Number_4_1999_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-D_Alloimmunization._ACOG_Practice_Bulletin_Number_4_1999_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Prevention of Rh D Alloimmunization. ACOG Practice Bulletin Number 4. Washington, DC: American College of Obstetricians and Gynecologists, 1999.</span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20081230200349/http://www.rcog.org.uk/index.asp?PageID=1972\">\"Use of Anti-D Immunoglobulin for Rh Prophylaxis\"</a>. <a href=\"/wiki/Royal_College_of_Obstetricians_and_Gynaecologists\" title=\"Royal College of Obstetricians and Gynaecologists\">Royal College of Obstetricians and Gynaecologists</a>. May 2002. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.rcog.org.uk/index.asp?PageID=1972\">the original</a> on 2008-12-30.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Use+of+Anti-D+Immunoglobulin+for+Rh+Prophylaxis&amp;rft.pub=Royal+College+of+Obstetricians+and+Gynaecologists&amp;rft.date=2002-05&amp;rft_id=http%3A%2F%2Fwww.rcog.org.uk%2Findex.asp%3FPageID%3D1972&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Karanth, L; Jaafar, SH; Kanagasabai, S; Nair, NS; Barua, A (Mar 28, 2013). \"Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation\". <i>The Cochrane Database of Systematic Reviews</i>. <b>3</b>: CD009617. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD009617.pub2\">10.1002/14651858.CD009617.pub2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23543581\">23543581</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Anti-D+administration+after+spontaneous+miscarriage+for+preventing+Rhesus+alloimmunisation.&amp;rft.volume=3&amp;rft.pages=CD009617&amp;rft.date=2013-03-28&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD009617.pub2&amp;rft_id=info%3Apmid%2F23543581&amp;rft.aulast=Karanth&amp;rft.aufirst=L&amp;rft.au=Jaafar%2C+SH&amp;rft.au=Kanagasabai%2C+S&amp;rft.au=Nair%2C+NS&amp;rft.au=Barua%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bowman JM (1985). \"Controversies in Rh Prophylaxis. Who Needs Rh Immune Globulin and When Should it be Given?\". <i>Am J Obstet Gynecol</i>. <b>151</b>: 289\u201394.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Obstet+Gynecol&amp;rft.atitle=Controversies+in+Rh+Prophylaxis.+Who+Needs+Rh+Immune+Globulin+and+When+Should+it+be+Given%3F&amp;rft.volume=151&amp;rft.pages=289-94&amp;rft.date=1985&amp;rft.au=Bowman+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\">Rudmann, Sally V. 2005. \"Textbook of Blood Banking and Transfusion Medicine 2nd Edition.\" ELSEVIER Saunders. pp 439-441</span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\">Klein Hg and Anstee DJ. Haemolytic Disease of the Fetus and Newborn. In: Mollison's Blood Transfusion in Clinical Medicine.  11th Ed. Oxford: Blackwell, 2005: 496-545.</span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Provan D, Stasi R, Newland AC,  et al. (2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://bloodjournal.hematologylibrary.org/content/115/2/168.full.pdf+html\">\"International consensus report on the investigation and management of primary immune thrombocytopenia\"</a>. <i>Blood</i>. <b>115</b> (2): 168\u2013186. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2009-06-225565\">10.1182/blood-2009-06-225565</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19846889\">19846889</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20131029200615/http://bloodjournal.hematologylibrary.org/content/115/2/168.full.pdf+html\">Archived</a> from the original on 2013-10-29.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=International+consensus+report+on+the+investigation+and+management+of+primary+immune+thrombocytopenia&amp;rft.volume=115&amp;rft.issue=2&amp;rft.pages=168-186&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2009-06-225565&amp;rft_id=info%3Apmid%2F19846889&amp;rft.aulast=Provan&amp;rft.aufirst=D&amp;rft.au=Stasi%2C+R&amp;rft.au=Newland%2C+AC&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcontent%2F115%2F2%2F168.full.pdf%2Bhtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\">Winrho SDF current prescribing information. Available: www.winrho.com.</span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Provan D, Stasi R, Newland AC,  et al. (2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://bloodjournal.hematologylibrary.org/content/115/2/168.full.pdf+html\">\"International consensus report on the investigation and management of primary immune thrombocytopenia\"</a>. <i>Blood</i>. <b>115</b>: 168\u2013186. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2009-06-225565\">10.1182/blood-2009-06-225565</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19846889\">19846889</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20131029200615/http://bloodjournal.hematologylibrary.org/content/115/2/168.full.pdf+html\">Archived</a> from the original on 2013-10-29.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=International+consensus+report+on+the+investigation+and+management+of+primary+immune+thrombocytopenia&amp;rft.volume=115&amp;rft.pages=168-186&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2009-06-225565&amp;rft_id=info%3Apmid%2F19846889&amp;rft.aulast=Provan&amp;rft.aufirst=D&amp;rft.au=Stasi%2C+R&amp;rft.au=Newland%2C+AC&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcontent%2F115%2F2%2F168.full.pdf%2Bhtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Neunert C, Lim W, Crowther M,  et al. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://bloodjournal.hematologylibrary.org/content/117/16/4190.full.pdf\">\"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Blood</i>. <b>117</b> (16): 4190\u20134207. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2010-08-302984\">10.1182/blood-2010-08-302984</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21325604\">21325604</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=The+American+Society+of+Hematology+2011+evidence-based+practice+guideline+for+immune+thrombocytopenia&amp;rft.volume=117&amp;rft.issue=16&amp;rft.pages=4190-4207&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2010-08-302984&amp;rft_id=info%3Apmid%2F21325604&amp;rft.aulast=Neunert&amp;rft.aufirst=C&amp;rft.au=Lim%2C+W&amp;rft.au=Crowther%2C+M&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcontent%2F117%2F16%2F4190.full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www2.vaxserve.com/views/PDF/RhoGAM%20Ultra-Filtered%20Plus%20Package%20Insert%207-07.pdf\">RhoGAM product label, includes clinical trial data and prescribing information</a><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since April 2018\">permanent dead link</span></a></i>&#93;</span></sup></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.rhophylac.com/AboutHDN/evolution.asp\">History of HDN Treatment</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20081121040322/http://www.rhophylac.com/AboutHDN/evolution.asp\">Archived</a> 2008-11-21 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.rhophylac.com/About/chromaplus.asp\">ChromaPlus Manufacturing Process</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20081121035457/http://www.rhophylac.com/About/chromaplus.asp\">Archived</a> 2008-11-21 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.jnj.com/innovations/new_features/RhoGAM.htm\">RhoGAM Ultra-Filtered PLUS Rho(D) Immune Globulin (Human) Information Site</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20060311120204/http://www.jnj.com/innovations/new_features/RhoGAM.htm\">Archived</a> 2006-03-11 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Staff (5 May 2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.highbeam.com/doc/1G1-225162858.html\">\"Cangene assumes U.S. commercialization rights for WinRho SDF\"</a>. <i><a href=\"/wiki/Biotech_Week\" title=\"Biotech Week\">Biotech Week</a></i>. United States. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150329105804/http://www.highbeam.com/doc/1G1-225162858.html\">Archived</a> from the original on 29 March 2015  &#8211; via <a href=\"/wiki/HighBeam_Research\" title=\"HighBeam Research\">HighBeam Research</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biotech+Week&amp;rft.atitle=Cangene+assumes+U.S.+commercialization+rights+for+WinRho+SDF&amp;rft.date=2010-05-05&amp;rft.au=Staff&amp;rft_id=http%3A%2F%2Fwww.highbeam.com%2Fdoc%2F1G1-225162858.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Cash, Martin (16 June 2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.highbeam.com/doc/1P3-2058879031.html\">\"Cangene Corp. begins transformation project\"</a>. <i><a href=\"/wiki/Winnipeg_Free_Press\" title=\"Winnipeg Free Press\">Winnipeg Free Press</a></i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150329105801/http://www.highbeam.com/doc/1P3-2058879031.html\">Archived</a> from the original on 29 March 2015  &#8211; via <a href=\"/wiki/HighBeam_Research\" title=\"HighBeam Research\">HighBeam Research</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Winnipeg+Free+Press&amp;rft.atitle=Cangene+Corp.+begins+transformation+project&amp;rft.date=2010-06-16&amp;rft.au=Cash%2C+Martin&amp;rft_id=http%3A%2F%2Fwww.highbeam.com%2Fdoc%2F1P3-2058879031.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARho%28D%29+immune+globulin\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Rho(D)_immune_globulin&amp;action=edit&amp;section=12\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.rhogam.com\">Rhogam Product Website</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20060311120204/http://www.jnj.com/innovations/new_features/RhoGAM.htm\">Product information</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://meshb.nlm.nih.gov/record/ui?name=Rho(D)%20Immune%20Globulin\">Rho(D)+Immune+Globulin</a> at the US National Library of Medicine <a href=\"/wiki/Medical_Subject_Headings\" title=\"Medical Subject Headings\">Medical Subject Headings</a> (MeSH)</li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Immune_sera_and_immunoglobulins_(J06)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Immune_sera_and_immunoglobulins\" title=\"Template:Immune sera and immunoglobulins\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Immune_sera_and_immunoglobulins\" title=\"Template talk:Immune sera and immunoglobulins\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Immune_sera_and_immunoglobulins&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Immune_sera_and_immunoglobulins_(J06)\" style=\"font-size:114%;margin:0 4em\">Immune sera and immunoglobulins (<a href=\"/wiki/ATC_code_J06\" title=\"ATC code J06\">J06</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Polyclonal_antibodies\" title=\"Polyclonal antibodies\">Polyclonal antibodies</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Intravenous_immunoglobulin\" class=\"mw-redirect\" title=\"Intravenous immunoglobulin\">IVIG</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Anthrax_immune_globulin\" title=\"Anthrax immune globulin\">Anthrax immune globulin</a></li>\n<li><a class=\"mw-selflink selflink\">Rho(D) immune globulin</a></li>\n<li><a href=\"/wiki/Hepatitis_B_immune_globulin\" title=\"Hepatitis B immune globulin\">Hepatitis B immune globulin</a></li>\n<li><a href=\"/wiki/Zoster-immune_globulin\" class=\"mw-redirect\" title=\"Zoster-immune globulin\">Zoster-immune globulin</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Antiserum\" title=\"Antiserum\">Antiserum</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Antivenom\" title=\"Antivenom\">Antivenom</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Monoclonal_antibody\" title=\"Monoclonal antibody\">Monoclonal antibodies</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Motavizumab\" title=\"Motavizumab\">Motavizumab</a></li>\n<li><a href=\"/wiki/Nebacumab\" title=\"Nebacumab\">Nebacumab</a></li>\n<li><a href=\"/wiki/Palivizumab\" title=\"Palivizumab\">Palivizumab</a></li>\n<li><a href=\"/wiki/Raxibacumab\" title=\"Raxibacumab\">Raxibacumab</a></li></ul>\n</div></td></tr></tbody></table></div>\n<div class=\"noprint metadata navbox\" role=\"navigation\" aria-label=\"Portals\" style=\"font-weight:bold;padding:0.4em 2em\"><ul style=\"margin:0.1em 0 0\"><li style=\"display:inline\"><span style=\"display:inline-block;white-space:nowrap\"><span style=\"margin:0 0.5em\"><a href=\"/wiki/File:Tabletten.JPG\" class=\"image\"><img alt=\"Tabletten.JPG\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Tabletten.JPG/24px-Tabletten.JPG\" width=\"24\" height=\"20\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Tabletten.JPG/36px-Tabletten.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Tabletten.JPG/48px-Tabletten.JPG 2x\" data-file-width=\"544\" data-file-height=\"450\" /></a></span><a href=\"/wiki/Portal:Pharmacy_and_pharmacology\" title=\"Portal:Pharmacy and pharmacology\">Pharmacy and pharmacology portal</a></span></li><li style=\"display:inline\"><span style=\"display:inline-block;white-space:nowrap\"><span style=\"margin:0 0.5em\"><a href=\"/wiki/File:WHO_Rod.svg\" class=\"image\"><img alt=\"WHO Rod.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/9px-WHO_Rod.svg.png\" width=\"9\" height=\"21\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/13px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/18px-WHO_Rod.svg.png 2x\" data-file-width=\"107\" data-file-height=\"250\" /></a></span><a href=\"/wiki/Portal:Medicine\" title=\"Portal:Medicine\">Medicine portal</a></span></li></ul></div>\n\n<!-- \nNewPP limit report\nParsed by mw2190\nCached time: 20180919024504\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.508 seconds\nReal time usage: 0.624 seconds\nPreprocessor visited node count: 4660/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 59635/2097152 bytes\nTemplate argument size: 2873/2097152 bytes\nHighest expansion depth: 14/40\nExpensive parser function count: 3/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 27388/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.206/10.000 seconds\nLua memory usage: 4.86 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  550.535      1 -total\n 51.76%  284.951      1 Template:Drugbox\n 35.21%  193.836      1 Template:Reflist\n 33.28%  183.208      1 Template:Infobox\n  9.29%   51.130     16 Template:Unbulleted_list\n  9.02%   49.666      7 Template:Cite_journal\n  7.97%   43.863      4 Template:Cite_web\n  5.91%   32.558      1 Template:Infobox_drug/chemical_formula\n  4.87%   26.807      1 Template:Dead_link\n  4.36%   23.979      1 Template:Redirect\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:3365974-0!canonical and timestamp 20180919024504 and revision id 850581461\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%A7%D9%84%D8%AC%D9%84%D9%88%D8%A8%D9%8A%D9%88%D9%84%D9%8A%D9%86_%D8%A7%D9%84%D9%85%D9%86%D8%A7%D8%B9%D9%8A_Rho(%D8%AF%D9%8A)","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0627\u0644\u062c\u0644\u0648\u0628\u064a\u0648\u0644\u064a\u0646 \u0627\u0644\u0645\u0646\u0627\u0639\u064a Rho(\u062f\u064a)"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Immunoglobuline_anti-D","langname":"French","autonym":"fran\u00e7ais","*":"Immunoglobuline anti-D"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E6%8A%97D%E3%83%92%E3%83%88%E5%85%8D%E7%96%AB%E3%82%B0%E3%83%AD%E3%83%96%E3%83%AA%E3%83%B3","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u6297D\u30d2\u30c8\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3"},{"lang":"or","url":"https://or.wikipedia.org/wiki/%E0%AC%86%E0%AC%B0%E0%AC%8F%E0%AC%9A%E0%AC%93_(%E0%AC%A1%E0%AC%BF)_%E0%AC%87%E0%AC%AE%E0%AD%8D%E0%AC%AE%E0%AD%8D%E0%AD%9F%E0%AD%81%E0%AC%A8_%E0%AC%97%E0%AD%8D%E0%AC%B2%E0%AD%8B%E0%AC%AC%E0%AD%8D%E0%AD%9F%E0%AD%81%E0%AC%B2%E0%AC%BF%E0%AC%A8","langname":"Odia","autonym":"\u0b13\u0b21\u0b3c\u0b3f\u0b06","*":"\u0b06\u0b30\u0b0f\u0b1a\u0b13 (\u0b21\u0b3f) \u0b07\u0b2e\u0b4d\u0b2e\u0b4d\u0b5f\u0b41\u0b28 \u0b17\u0b4d\u0b32\u0b4b\u0b2c\u0b4d\u0b5f\u0b41\u0b32\u0b3f\u0b28"},{"lang":"th","url":"https://th.wikipedia.org/wiki/%E0%B8%AD%E0%B8%B4%E0%B8%A1%E0%B8%A1%E0%B8%B9%E0%B9%82%E0%B8%99%E0%B9%82%E0%B8%81%E0%B8%A5%E0%B8%9A%E0%B8%B8%E0%B8%A5%E0%B8%B4%E0%B8%99%E0%B8%95%E0%B9%88%E0%B8%AD_Rho(D)","langname":"Thai","autonym":"\u0e44\u0e17\u0e22","*":"\u0e2d\u0e34\u0e21\u0e21\u0e39\u0e42\u0e19\u0e42\u0e01\u0e25\u0e1a\u0e38\u0e25\u0e34\u0e19\u0e15\u0e48\u0e2d Rho(D)"}],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_April_2018"},{"sortkey":"","hidden":"","*":"Articles_with_permanently_dead_external_links"},{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"M","hidden":"","*":"Template:drugs.com_link_with_non-standard_subpage"},{"sortkey":"*","hidden":"","*":"Chemicals_that_do_not_have_a_ChemSpider_ID_assigned"},{"sortkey":"","hidden":"","*":"Infobox_drug_articles_without_a_structure_image"},{"sortkey":"*","hidden":"","*":"Chemical_articles_without_CAS_registry_number"},{"sortkey":"*","hidden":"","*":"Articles_without_EBI_source"},{"sortkey":"*","hidden":"","*":"Chemical_pages_without_DrugBank_identifier"},{"sortkey":"*","hidden":"","*":"Articles_without_KEGG_source"},{"sortkey":"*","hidden":"","*":"Articles_without_InChI_source"},{"sortkey":"*","hidden":"","*":"Articles_without_UNII_source"},{"sortkey":"","hidden":"","*":"Drugs_with_no_legal_status"},{"sortkey":"","hidden":"","*":"Drugboxes_which_contain_changes_to_verified_fields"},{"sortkey":"","*":"Polyclonal_antibodies"},{"sortkey":"Immunology","*":"Immunology"},{"sortkey":"","*":"Obstetrics"},{"sortkey":"","*":"Drugs_acting_on_the_blood_and_blood_forming_organs"},{"sortkey":"","*":"Pediatrics"},{"sortkey":"","*":"Transfusion_medicine"},{"sortkey":"","*":"Health_issues_in_pregnancy"},{"sortkey":"","hidden":"","*":"RTT"},{"sortkey":"","*":"World_Health_Organization_essential_medicines"}],"links":[{"ns":0,"exists":"","*":"Anti-D"},{"ns":0,"*":"Rho(D) immune globulin (data page)"},{"ns":0,"exists":"","*":"ATC code J06"},{"ns":0,"exists":"","*":"Abortion"},{"ns":0,"exists":"","*":"Allergic reactions"},{"ns":0,"exists":"","*":"Alloimmunity"},{"ns":0,"exists":"","*":"American College of Obstetricians and Gynecologists"},{"ns":0,"exists":"","*":"American Journal of Obstetrics and Gynecology"},{"ns":0,"exists":"","*":"American Society of Health-System Pharmacists"},{"ns":0,"exists":"","*":"Anatomical Therapeutic Chemical Classification System"},{"ns":0,"exists":"","*":"Antenatal"},{"ns":0,"exists":"","*":"Anthrax immune globulin"},{"ns":0,"exists":"","*":"Anti-D (song)"},{"ns":0,"exists":"","*":"Antibodies"},{"ns":0,"exists":"","*":"Antigen"},{"ns":0,"exists":"","*":"Antiserum"},{"ns":0,"exists":"","*":"Antivenom"},{"ns":0,"exists":"","*":"Baxter International"},{"ns":0,"exists":"","*":"Biotech Week"},{"ns":0,"exists":"","*":"Blood plasma"},{"ns":0,"exists":"","*":"Blood types"},{"ns":0,"exists":"","*":"Breastfeeding"},{"ns":0,"exists":"","*":"CSL Behring"},{"ns":0,"exists":"","*":"Cangene"},{"ns":0,"exists":"","*":"ChemSpider"},{"ns":0,"exists":"","*":"Cochrane review"},{"ns":0,"exists":"","*":"Cohn process"},{"ns":0,"exists":"","*":"Creutzfeldt\u2013Jakob disease"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Direct antiglobulin test"},{"ns":0,"exists":"","*":"Distribution (business)"},{"ns":0,"exists":"","*":"Drug nomenclature"},{"ns":0,"exists":"","*":"Drugs.com"},{"ns":0,"exists":"","*":"Erythroblastosis fetalis"},{"ns":0,"exists":"","*":"Fc receptor"},{"ns":0,"exists":"","*":"Fetus"},{"ns":0,"exists":"","*":"Fever"},{"ns":0,"exists":"","*":"Flow cytometry"},{"ns":0,"exists":"","*":"Food and Drug Administration (United States)"},{"ns":0,"exists":"","*":"Health system"},{"ns":0,"exists":"","*":"Hemolysis"},{"ns":0,"exists":"","*":"Hepatitis B immune globulin"},{"ns":0,"exists":"","*":"Heterozygous"},{"ns":0,"exists":"","*":"HighBeam Research"},{"ns":0,"exists":"","*":"Homozygous"},{"ns":0,"exists":"","*":"Human blood plasma"},{"ns":0,"exists":"","*":"Idiopathic thrombocytopenic purpura"},{"ns":0,"exists":"","*":"Immune thrombocytopenia"},{"ns":0,"exists":"","*":"Immunology"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Intramuscular injection"},{"ns":0,"exists":"","*":"Intravenous"},{"ns":0,"exists":"","*":"Intravenous immunoglobulin"},{"ns":0,"exists":"","*":"James Harrison (blood donor)"},{"ns":0,"exists":"","*":"Kidney problems"},{"ns":0,"exists":"","*":"Kleihauer-Betke test"},{"ns":0,"exists":"","*":"Macrophages"},{"ns":0,"exists":"","*":"Medical Subject Headings"},{"ns":0,"exists":"","*":"Monoclonal antibody"},{"ns":0,"exists":"","*":"Motavizumab"},{"ns":0,"exists":"","*":"NHS"},{"ns":0,"exists":"","*":"National Institute for Health and Clinical Excellence"},{"ns":0,"exists":"","*":"Nebacumab"},{"ns":0,"exists":"","*":"Newborn"},{"ns":0,"exists":"","*":"O"},{"ns":0,"exists":"","*":"OCLC"},{"ns":0,"exists":"","*":"Palivizumab"},{"ns":0,"exists":"","*":"Platelet count"},{"ns":0,"exists":"","*":"Platelets"},{"ns":0,"exists":"","*":"Polyclonal antibodies"},{"ns":0,"exists":"","*":"Pregnancy"},{"ns":0,"exists":"","*":"Pregnancy category"},{"ns":0,"exists":"","*":"Prion"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Raxibacumab"},{"ns":0,"exists":"","*":"Red blood cells"},{"ns":0,"exists":"","*":"Rh blood group system"},{"ns":0,"exists":"","*":"Rh disease"},{"ns":0,"exists":"","*":"Rh isoimmunization"},{"ns":0,"exists":"","*":"Rh negative"},{"ns":0,"exists":"","*":"Rh positive"},{"ns":0,"exists":"","*":"Rhesus blood group system"},{"ns":0,"exists":"","*":"Rosette test"},{"ns":0,"exists":"","*":"Route of administration"},{"ns":0,"exists":"","*":"Royal College of Obstetricians and Gynaecologists"},{"ns":0,"exists":"","*":"Thrombocytopenia"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":0,"exists":"","*":"Weak D"},{"ns":0,"exists":"","*":"Winnipeg Free Press"},{"ns":0,"exists":"","*":"World Health Organization's List of Essential Medicines"},{"ns":0,"exists":"","*":"Zero"},{"ns":0,"exists":"","*":"Zoster-immune globulin"},{"ns":0,"*":"Jskymed"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from April 2018"},{"ns":10,"exists":"","*":"Template:Immune sera and immunoglobulins"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"},{"ns":4,"exists":"","*":"Wikipedia:WikiProject Chemicals/Chembox validation"},{"ns":11,"exists":"","*":"Template talk:Immune sera and immunoglobulins"},{"ns":100,"exists":"","*":"Portal:Medicine"},{"ns":100,"exists":"","*":"Portal:Pharmacy and pharmacology"}],"templates":[{"ns":10,"exists":"","*":"Template:Redirect"},{"ns":10,"exists":"","*":"Template:Drugbox"},{"ns":10,"exists":"","*":"Template:Infobox drug"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Infobox drug/title"},{"ns":10,"exists":"","*":"Template:Drugs.com"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Infobox drug/licence"},{"ns":10,"exists":"","*":"Template:Infobox drug/pregnancy category"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatATC"},{"ns":10,"exists":"","*":"Template:Infobox drug/legal status"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatCASnumber"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemCID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemSID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatIUPHARBPS"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatDrugBank"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemSpider"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatUNII"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatKEGG"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEBI"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEMBL"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemDBNIAID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPDBligand"},{"ns":10,"exists":"","*":"Template:Infobox drug/chemical formula"},{"ns":10,"exists":"","*":"Template:Chembox Elements/molecular formula"},{"ns":10,"exists":"","*":"Template:Chem molar mass"},{"ns":10,"exists":"","*":"Template:Chem molar mass/format"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatJmol"},{"ns":10,"exists":"","*":"Template:Nobold"},{"ns":10,"exists":"","*":"Template:Cross"},{"ns":10,"exists":"","*":"Template:Tick"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Button"},{"ns":10,"exists":"","*":"Template:Border-radius"},{"ns":10,"exists":"","*":"Template:Linear-gradient"},{"ns":10,"exists":"","*":"Template:Chemspidercite"},{"ns":10,"exists":"","*":"Template:Cascite"},{"ns":10,"exists":"","*":"Template:Drugbankcite"},{"ns":10,"exists":"","*":"Template:Infobox drug/maintenance categories"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:MeshName"},{"ns":10,"exists":"","*":"Template:MeSH name"},{"ns":10,"exists":"","*":"Template:Immune sera and immunoglobulins"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Portal bar"},{"ns":828,"exists":"","*":"Module:Redirect hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Redirect"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:TemplatePar"},{"ns":828,"exists":"","*":"Module:ParameterCount"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Portal bar"},{"ns":828,"exists":"","*":"Module:Portal"},{"ns":828,"exists":"","*":"Module:Portal/images/p"},{"ns":828,"exists":"","*":"Module:Portal/images/m"},{"ns":0,"exists":"","*":"Anti-D"}],"images":["X_mark.svg","Yes_check.svg","Tabletten.JPG","WHO_Rod.svg"],"externallinks":["https://www.drugs.com/monograph/rho-d-immune-globulin.html","https://web.archive.org/web/20170109021739/https://www.drugs.com/monograph/rho-d-immune-globulin.html","https://books.google.ca/books?id=WMsWpXjnWWYC&pg=PA251","//www.worldcat.org/oclc/968617246","http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1","https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1","//doi.org/10.1097/AOG.0000000000002232","//www.ncbi.nlm.nih.gov/pubmed/28742673","http://www.nice.org.uk/guidance/TA41/?c=91520","https://web.archive.org/web/20080828175059/http://www.nice.org.uk/guidance/TA41/?c=91520","https://web.archive.org/web/20081230200349/http://www.rcog.org.uk/index.asp?PageID=1972","http://www.rcog.org.uk/index.asp?PageID=1972","//doi.org/10.1002/14651858.CD009617.pub2","//www.ncbi.nlm.nih.gov/pubmed/23543581","http://bloodjournal.hematologylibrary.org/content/115/2/168.full.pdf+html","//doi.org/10.1182/blood-2009-06-225565","//www.ncbi.nlm.nih.gov/pubmed/19846889","https://web.archive.org/web/20131029200615/http://bloodjournal.hematologylibrary.org/content/115/2/168.full.pdf+html","http://bloodjournal.hematologylibrary.org/content/117/16/4190.full.pdf","//doi.org/10.1182/blood-2010-08-302984","//www.ncbi.nlm.nih.gov/pubmed/21325604","https://www2.vaxserve.com/views/PDF/RhoGAM%20Ultra-Filtered%20Plus%20Package%20Insert%207-07.pdf","http://www.rhophylac.com/AboutHDN/evolution.asp","https://web.archive.org/web/20081121040322/http://www.rhophylac.com/AboutHDN/evolution.asp","http://www.rhophylac.com/About/chromaplus.asp","https://web.archive.org/web/20081121035457/http://www.rhophylac.com/About/chromaplus.asp","http://www.jnj.com/innovations/new_features/RhoGAM.htm","https://web.archive.org/web/20060311120204/http://www.jnj.com/innovations/new_features/RhoGAM.htm","http://www.highbeam.com/doc/1G1-225162858.html","https://web.archive.org/web/20150329105804/http://www.highbeam.com/doc/1G1-225162858.html","http://www.highbeam.com/doc/1P3-2058879031.html","https://web.archive.org/web/20150329105801/http://www.highbeam.com/doc/1P3-2058879031.html","https://www.whocc.no/atc_ddd_index/?code=J06BB01","http://www.winrho.com","http://www.cangene.com","http://www.rhogam.com","https://meshb.nlm.nih.gov/record/ui?name=Rho(D)%20Immune%20Globulin"],"sections":[{"toclevel":1,"level":"2","line":"Medical uses","number":"1","index":"1","fromtitle":"Rho(D)_immune_globulin","byteoffset":4418,"anchor":"Medical_uses"},{"toclevel":2,"level":"3","line":"Following delivery","number":"1.1","index":"2","fromtitle":"Rho(D)_immune_globulin","byteoffset":10427,"anchor":"Following_delivery"},{"toclevel":2,"level":"3","line":"Immune thrombocytopenia","number":"1.2","index":"3","fromtitle":"Rho(D)_immune_globulin","byteoffset":13078,"anchor":"Immune_thrombocytopenia"},{"toclevel":1,"level":"2","line":"Contraindications","number":"2","index":"4","fromtitle":"Rho(D)_immune_globulin","byteoffset":16136,"anchor":"Contraindications"},{"toclevel":1,"level":"2","line":"History","number":"3","index":"5","fromtitle":"Rho(D)_immune_globulin","byteoffset":16501,"anchor":"History"},{"toclevel":1,"level":"2","line":"Society and culture","number":"4","index":"6","fromtitle":"Rho(D)_immune_globulin","byteoffset":17416,"anchor":"Society_and_culture"},{"toclevel":2,"level":"3","line":"Manufacturing and safety","number":"4.1","index":"7","fromtitle":"Rho(D)_immune_globulin","byteoffset":17440,"anchor":"Manufacturing_and_safety"},{"toclevel":2,"level":"3","line":"Routes of administration","number":"4.2","index":"8","fromtitle":"Rho(D)_immune_globulin","byteoffset":19070,"anchor":"Routes_of_administration"},{"toclevel":2,"level":"3","line":"Names","number":"4.3","index":"9","fromtitle":"Rho(D)_immune_globulin","byteoffset":19531,"anchor":"Names"},{"toclevel":1,"level":"2","line":"See also","number":"5","index":"10","fromtitle":"Rho(D)_immune_globulin","byteoffset":21356,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"11","fromtitle":"Rho(D)_immune_globulin","byteoffset":21576,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"7","index":"12","fromtitle":"Rho(D)_immune_globulin","byteoffset":21609,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Rho(D) immune globulin","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q3149137"}]}}